On Nov 4, 2021 Platelet BioGenesis closed a Series B round and raised $75,500,000 from K2 HealthVentures, Oxford Finance LLC, Qiming Venture Partners, SymBiosis LLC, Ziff Capital Partners, featuring lead investors SymBiosis LLC.
About the company: Platelet BioGenesis is located at United States, North America.
“Recreating natureâs legendary cell. Inspired by platelet biology, we are pioneering an entirely new class of cell-based therapeutics.”
Company website: http://www.plateletbio.com
